Terumo enters consent decree with FDA banning sales of cardiac surgery devices to new customers
This article was originally published in Clinica
Executive Summary
The US Department of Justice last Thursday (24 March) filed a consent decree between Terumo's US heart device unit and the FDA, which prohibits the company from manufacturing and distributing worldwide, to new customers, several of its products used during cardiac surgery, including two heart-lung bypass systems.